CY1107467T1 - Χρηση οξεογονων υδρογονοτροφων στελεχων για την προληψη ή την αγωγη πεπτικων διαταραχων - Google Patents
Χρηση οξεογονων υδρογονοτροφων στελεχων για την προληψη ή την αγωγη πεπτικων διαταραχωνInfo
- Publication number
- CY1107467T1 CY1107467T1 CY20061100815T CY061100815T CY1107467T1 CY 1107467 T1 CY1107467 T1 CY 1107467T1 CY 20061100815 T CY20061100815 T CY 20061100815T CY 061100815 T CY061100815 T CY 061100815T CY 1107467 T1 CY1107467 T1 CY 1107467T1
- Authority
- CY
- Cyprus
- Prior art keywords
- oxogenous
- hydro
- prevention
- treatment
- digestive disorders
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
- A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/66—Microorganisms or materials therefrom
- A61K35/74—Bacteria
- A61K35/741—Probiotics
- A61K35/742—Spore-forming bacteria, e.g. Bacillus coagulans, Bacillus subtilis, clostridium or Lactobacillus sporogenes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/822—Microorganisms using bacteria or actinomycetales
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Treatments Of Macromolecular Shaped Articles (AREA)
- Jellies, Jams, And Syrups (AREA)
Abstract
Η εφεύρεση αφορά τη χρήση μη παθογόνων βακτηριακών οξεογόνων υδρογονοτρόφων στελεχών για την παρασκευή μίας συνθέσεως προοριζόμενης για την αγωγή ή την πρόληψη των γαστρεντερικών διαταραχών των σχετιζόμενων με την παραγωγή πεπτικών αερίων και/ή για τη ρύθμιση της μικροβιακής ισορροπίας του πεπτικού οικοσυστήματος στα θηλαστικά. Η εφεύρεση αφορά επίσης τις εv λόγω φαρμακευτικές ή διατροφικές συνθέσεις, καθώς και μεθόδους παρακολουθήσεως και παρασκευής των εν λόγω στελεχών.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0006009A FR2808689B1 (fr) | 2000-05-11 | 2000-05-11 | Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement de troubles digestifs |
EP01934089A EP1280541B2 (fr) | 2000-05-11 | 2001-05-11 | Utilisation de souches acetogenes hydrogenotrophes pour la prevention ou le traitement du syndrome de l'intestin irritable |
Publications (1)
Publication Number | Publication Date |
---|---|
CY1107467T1 true CY1107467T1 (el) | 2012-12-19 |
Family
ID=8850107
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CY20061100815T CY1107467T1 (el) | 2000-05-11 | 2006-06-19 | Χρηση οξεογονων υδρογονοτροφων στελεχων για την προληψη ή την αγωγη πεπτικων διαταραχων |
Country Status (13)
Country | Link |
---|---|
US (2) | US7749494B2 (el) |
EP (1) | EP1280541B2 (el) |
JP (1) | JP5183848B2 (el) |
AT (1) | ATE322902T1 (el) |
AU (2) | AU6040001A (el) |
CA (1) | CA2411563C (el) |
CY (1) | CY1107467T1 (el) |
DE (1) | DE60118723T3 (el) |
DK (1) | DK1280541T4 (el) |
ES (1) | ES2262650T5 (el) |
FR (1) | FR2808689B1 (el) |
PT (1) | PT1280541E (el) |
WO (1) | WO2001085187A1 (el) |
Families Citing this family (76)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AUPQ899700A0 (en) | 2000-07-25 | 2000-08-17 | Borody, Thomas Julius | Probiotic recolonisation therapy |
JP4618970B2 (ja) * | 2002-08-02 | 2011-01-26 | マルホ株式会社 | 肛門圧低下外用剤 |
US7935334B2 (en) * | 2005-07-07 | 2011-05-03 | Imagilin Technologies, LLC | Probiotics as alternative medicines against infectious diseases |
US20060008511A1 (en) * | 2004-07-08 | 2006-01-12 | Jhy-Jhu Lin | Probiotic products for pet applications |
DE102006062250A1 (de) * | 2006-12-22 | 2008-06-26 | Roland Saur-Brosch | Verwendung einer Zusammensetzung aus Mineralstoffen und/oder Vitaminen und gegebenenfalls acetogenen und/oder butyrogenen Bakterien zur oralen oder rektalen Verabreichung für die Behandlung und Vorbeugung von abdominalen Beschwerden |
PL2072053T3 (pl) * | 2007-12-21 | 2013-02-28 | Gervais Danone Sa | Sposób zmniejszania obwodu brzucha przez podawanie bakterii bifidobacterium |
EP2130543A1 (en) | 2008-06-05 | 2009-12-09 | Compagnie Gervais Danone | Method for decreasing borborygmi by administering a bifidobacterium bacteria |
DK3564357T3 (da) | 2010-02-01 | 2022-06-20 | Rebiotix Inc | Bakterieterapi mod clostridium difficile colitis |
WO2011151941A1 (ja) | 2010-06-04 | 2011-12-08 | 国立大学法人東京大学 | 制御性t細胞の増殖または集積を誘導する作用を有する組成物 |
HK1253538A1 (zh) * | 2010-08-04 | 2019-06-21 | Borody Thomas J | 用於糞便菌群植入的組合物及其製備和使用方法 |
KR20130098320A (ko) | 2010-08-04 | 2013-09-04 | 토마스 줄리어스 보로디 | 분변 세균총 이식을 위한 조성물, 그의 제조 방법과 사용 방법, 및 그를 전달하기 위한 장치 |
KR101805873B1 (ko) * | 2011-08-03 | 2018-01-10 | 한화케미칼 주식회사 | 단당류 인산 또는 그 유도체로 표면이 개질된 친수성 나노입자, 그의 콜로이드 용액 및 그 용도 |
EP2683390B1 (en) | 2011-03-09 | 2017-05-03 | Regents Of The University Of Minnesota | Compositions and methods for transplantation of colon microbiota |
GB201112091D0 (en) | 2011-07-14 | 2011-08-31 | Gt Biolog Ltd | Bacterial strains isolated from pigs |
GB201117313D0 (en) | 2011-10-07 | 2011-11-16 | Gt Biolog Ltd | Bacterium for use in medicine |
CA2892588A1 (en) | 2011-12-01 | 2013-06-06 | School Corporation, Azabu Veterinary Medicine Educational Institution | Human-derived bacteria that induce proliferation or accumulation of regulatory t cells |
CA3008794C (en) | 2012-03-29 | 2021-03-16 | Therabiome, Llc | Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix |
US9719144B2 (en) | 2012-05-25 | 2017-08-01 | Arizona Board Of Regents | Microbiome markers and therapies for autism spectrum disorders |
CA2904389C (en) | 2013-03-14 | 2018-09-18 | Jerome J. Schentag | Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents |
GB201306536D0 (en) | 2013-04-10 | 2013-05-22 | Gt Biolog Ltd | Polypeptide and immune modulation |
US9782445B2 (en) | 2013-06-05 | 2017-10-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9511099B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9511100B2 (en) | 2013-06-05 | 2016-12-06 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US10383901B2 (en) | 2013-06-05 | 2019-08-20 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
US9694039B2 (en) | 2013-06-05 | 2017-07-04 | Rebiotix, Inc. | Microbiota restoration therapy (MRT), compositions and methods of manufacture |
EP4234011A3 (en) | 2013-06-05 | 2023-09-20 | Rebiotix, Inc. | Microbiota restoration therapy (mrt), compositions and methods of manufacture |
MA41020A (fr) * | 2014-11-25 | 2017-10-03 | Evelo Biosciences Inc | Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome |
KR102523805B1 (ko) | 2014-12-23 | 2023-04-20 | 4디 파마 리서치 리미티드 | 면역 조정 |
EP3400953A1 (en) | 2014-12-23 | 2018-11-14 | 4D Pharma Research Limited | Pirin polypeptide and immune modulation |
BR112017018257A2 (pt) * | 2015-02-27 | 2018-04-10 | White Dog Labs Inc | método de fermentação mixotrópica para produzir acetona, isopropanol, ácido butírico e outros bioprodutos, e misturas dos mesmos |
US10793847B2 (en) | 2015-05-11 | 2020-10-06 | Mybiotics Pharma Ltd. | Systems and methods for growing a biofilm of probiotic bacteria on solid particles for colonization of bacteria in the gut |
EP3294307A4 (en) | 2015-05-14 | 2019-01-23 | Crestovo Holdings Llc | COMPOSITIONS FOR TRANSPLANTATION OF FECAL FLORA AND METHODS OF PREPARATION AND USE THEREOF, AND DEVICES FOR THEIR ADMINISTRATION |
NZ776366A (en) | 2015-05-22 | 2023-02-24 | Univ Minnesota | Methods for treating autism spectrum disorder and associated symptoms |
US10799539B2 (en) | 2015-06-09 | 2020-10-13 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
AU2016274757B2 (en) | 2015-06-09 | 2019-02-07 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
US10828340B2 (en) | 2015-06-09 | 2020-11-10 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
US10905726B2 (en) | 2015-06-09 | 2021-02-02 | Rebiotix, Inc. | Microbiota restoration therapy (MRT) compositions and methods of manufacture |
MA41010B1 (fr) | 2015-06-15 | 2020-01-31 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
PT3240554T (pt) * | 2015-06-15 | 2019-11-04 | 4D Pharma Res Ltd | Blautia stercosis e wexlerae para uso no tratamento de doenças inflamatórias e autoimunes |
MA41060B1 (fr) | 2015-06-15 | 2019-11-29 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
DK3206700T3 (da) | 2015-06-15 | 2019-08-05 | 4D Pharma Res Ltd | Sammensætninger omfattende bakteriestammer |
PT3307288T (pt) | 2015-06-15 | 2019-10-17 | 4D Pharma Res Ltd | Composições compreendendo estirpes bacterianas |
KR101914245B1 (ko) | 2015-11-20 | 2018-11-02 | 4디 파마 리서치 리미티드 | 박테리아성 균주를 함유한 조성물 |
GB201520497D0 (en) | 2015-11-20 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520638D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
GB201520631D0 (en) | 2015-11-23 | 2016-01-06 | 4D Pharma Res Ltd | Compositions comprising bacterial strains |
MA42560B1 (fr) * | 2016-03-04 | 2019-07-31 | 4D Pharma Plc | Compositions comprenant des souches bactériennes de blautia pour le traitement de l'hypersensibilité viscérale |
GB201612191D0 (en) | 2016-07-13 | 2016-08-24 | 4D Pharma Plc | Compositions comprising bacterial strains |
CN109562132B (zh) | 2016-05-25 | 2024-04-16 | 迈彼欧提克斯制药有限公司 | 用于小型生物群疗法的组合物和方法 |
US20170360848A1 (en) | 2016-06-15 | 2017-12-21 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods for treating autism spectrum disorder and associated symptoms |
US10849936B2 (en) | 2016-07-01 | 2020-12-01 | Regents Of The University Of Minnesota | Compositions and methods for C. difficile treatment |
GB201703552D0 (en) * | 2017-03-06 | 2017-04-19 | 4D Pharma Plc | Compositions comprising bacterial strains |
GB201703548D0 (en) * | 2017-03-06 | 2017-04-19 | 4D Pharma Plc | Compositions comprising bacterial strains |
TW201821093A (zh) * | 2016-07-13 | 2018-06-16 | 英商4D製藥有限公司 | 包含細菌菌株之組合物 |
US20180036352A1 (en) | 2016-08-03 | 2018-02-08 | Crestovo Holdings Llc | Methods for treating ulcerative colitis |
US10092601B2 (en) | 2016-10-11 | 2018-10-09 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
WO2018071537A1 (en) | 2016-10-11 | 2018-04-19 | Crestovo Holdings Llc | Compositions and methods for treating multiple sclerosis and related disorders |
US11213549B2 (en) | 2016-10-11 | 2022-01-04 | Finch Therapeutics Holdings Llc | Compositions and method for treating primary sclerosing cholangitis and related disorders |
GB201621123D0 (en) | 2016-12-12 | 2017-01-25 | 4D Pharma Plc | Compositions comprising bacterial strains |
WO2018187464A1 (en) | 2017-04-05 | 2018-10-11 | Crestovo Holdings Llc | Compositions and methods for treating diverticulitis and related disorders |
AU2018250206A1 (en) | 2017-04-05 | 2019-10-31 | Crestovo Holdings Llc | Compositions and methods for treating parkinson's disease (PD) and related disorders |
TW201907928A (zh) | 2017-05-22 | 2019-03-01 | 英商4D製藥研究有限公司 | 包含細菌品系之組成物 |
MA41708A (fr) | 2017-05-24 | 2020-04-08 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
AU2018272048B2 (en) | 2017-05-26 | 2024-04-04 | Finch Therapeutics Holdings Llc | Lyophilized compositions comprising fecal microbe-based therapeutic agents and methods for making and using same |
ES2841902T3 (es) | 2017-06-14 | 2021-07-12 | 4D Pharma Res Ltd | Composiciones que comprenden cepas bacterianas |
MA49425A (fr) | 2017-06-14 | 2020-04-22 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
EP3664823B1 (en) | 2017-08-07 | 2024-06-05 | Finch Therapeutics Holdings LLC | Composition for use in preventing or treating an enterococcal blood stream infection |
CN112312896A (zh) | 2018-06-19 | 2021-02-02 | 4D制药研究有限公司 | 包含活生物治疗产品的剂型 |
US11166990B2 (en) | 2018-07-13 | 2021-11-09 | Finch Therapeutics Holdings Llc | Methods and compositions for treating ulcerative colitis |
MA53155A (fr) | 2018-07-16 | 2021-05-26 | 4D Pharma Res Ltd | Compositions comprenant des souches bactériennes |
CA3114423A1 (en) | 2018-09-27 | 2020-04-02 | Finch Therapeutics Holdings Llc | Compositions and methods for treating epilepsy and related disorders |
EP3917550B1 (en) | 2019-05-10 | 2024-01-24 | CJ Bioscience, Inc. | Compositions comprising blautia hydrogenotrophica in the treatemnt of fibromyalgia |
WO2021044376A1 (en) * | 2019-09-05 | 2021-03-11 | White Dog Labs, Inc. | Mixotrophic probiotic compositions and uses thereof in the treatment of bloating |
EP3839039A1 (en) | 2019-12-16 | 2021-06-23 | 4D Pharma Research Limited | Providing bacterial biomass with improved storage stability |
TW202220639A (zh) | 2020-08-06 | 2022-06-01 | 英商4D製藥有限公司 | 凍乾方法 |
KR20230112700A (ko) | 2020-11-26 | 2023-07-27 | 4디 파마 레온, 에스.엘.유. | 방법 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5443826A (en) * | 1988-08-02 | 1995-08-22 | Borody; Thomas J. | Treatment of gastro-intestinal disorders with a fecal composition or a composition of bacteroides and E. Coli |
AUPM823094A0 (en) | 1994-09-16 | 1994-10-13 | Goodman Fielder Limited | Probiotic compositions |
AUPM864894A0 (en) * | 1994-10-07 | 1994-11-03 | Borody, Thomas Julius | Treatment of bowel-dependent neurological disorders |
AUPN698495A0 (en) | 1995-12-06 | 1996-01-04 | Pharma Pacific Pty Ltd | Improved therapeutic formulation and method |
KR20000064729A (ko) * | 1996-03-20 | 2000-11-06 | 번스 필프 앤드 컴파니 리미티드 | 위장관에서의미생물개체군의변경 |
SE511524C2 (sv) | 1997-06-02 | 1999-10-11 | Essum Ab | Lactobacillus casei rhamnosus-stam samt farmaceutisk beredning för bekämpning av patogena tarmbakterier |
DE19826928A1 (de) * | 1998-06-17 | 1999-12-23 | Novartis Consumer Health Gmbh | Arzneimittel, lebensfähige anaerobe Bakterien enthaltend, die die Sulfatreduktion sulfatreduzierender Bakterien hemmen |
WO2000010581A1 (fr) * | 1998-08-20 | 2000-03-02 | Miyarisan Pharmaceutical Co., Ltd. | Medicaments comprenant une combinaison d'une bacterie produisant de l'acide butyrique, et d'un constituant d'acide biliaire |
-
2000
- 2000-05-11 FR FR0006009A patent/FR2808689B1/fr not_active Expired - Lifetime
-
2001
- 2001-05-11 ES ES01934089T patent/ES2262650T5/es not_active Expired - Lifetime
- 2001-05-11 AT AT01934089T patent/ATE322902T1/de active
- 2001-05-11 DK DK01934089.2T patent/DK1280541T4/da active
- 2001-05-11 JP JP2001581840A patent/JP5183848B2/ja not_active Expired - Lifetime
- 2001-05-11 AU AU6040001A patent/AU6040001A/xx active Pending
- 2001-05-11 PT PT01934089T patent/PT1280541E/pt unknown
- 2001-05-11 AU AU2001260400A patent/AU2001260400B2/en not_active Expired
- 2001-05-11 US US10/275,706 patent/US7749494B2/en not_active Expired - Lifetime
- 2001-05-11 EP EP01934089A patent/EP1280541B2/fr not_active Expired - Lifetime
- 2001-05-11 CA CA2411563A patent/CA2411563C/fr not_active Expired - Lifetime
- 2001-05-11 WO PCT/FR2001/001426 patent/WO2001085187A1/fr active IP Right Grant
- 2001-05-11 DE DE60118723T patent/DE60118723T3/de not_active Expired - Lifetime
-
2006
- 2006-06-19 CY CY20061100815T patent/CY1107467T1/el unknown
-
2010
- 2010-04-15 US US12/760,926 patent/US20100316617A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
EP1280541B1 (fr) | 2006-04-12 |
EP1280541B2 (fr) | 2010-03-17 |
CA2411563A1 (fr) | 2001-11-15 |
FR2808689A1 (fr) | 2001-11-16 |
AU2001260400B2 (en) | 2006-10-26 |
DE60118723D1 (de) | 2006-05-24 |
ATE322902T1 (de) | 2006-04-15 |
DE60118723T2 (de) | 2006-12-28 |
JP5183848B2 (ja) | 2013-04-17 |
CA2411563C (fr) | 2012-12-11 |
DK1280541T4 (da) | 2010-07-05 |
WO2001085187A1 (fr) | 2001-11-15 |
US20030147858A1 (en) | 2003-08-07 |
EP1280541A1 (fr) | 2003-02-05 |
JP2004501095A (ja) | 2004-01-15 |
US7749494B2 (en) | 2010-07-06 |
AU6040001A (en) | 2001-11-20 |
PT1280541E (pt) | 2006-06-30 |
ES2262650T3 (es) | 2006-12-01 |
DE60118723T3 (de) | 2010-09-30 |
DK1280541T3 (da) | 2006-07-17 |
FR2808689B1 (fr) | 2004-09-03 |
US20100316617A1 (en) | 2010-12-16 |
ES2262650T5 (es) | 2010-06-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1107467T1 (el) | Χρηση οξεογονων υδρογονοτροφων στελεχων για την προληψη ή την αγωγη πεπτικων διαταραχων | |
DK1539166T3 (da) | Farmaceutiske sammensætninger indeholdende dextromethorphan og quinidin til behandling af neurologiske sygdomme | |
NO20061736L (no) | Krystallform av epotilon B | |
DK1781277T3 (da) | Kombinationssammensætning, der omfatter Ibuprofen og Paracetamol | |
TR199901417T2 (xx) | Analjezik etkisi olan yeni bile�imler. | |
ATE413386T1 (de) | Ppar-gamma modulatoren | |
DK1169060T3 (da) | Natriumkanalblokkerpræparater og anvendelse deraf | |
DE602004026113D1 (de) | Glp-1-verbindungen | |
BRPI0411319A (pt) | compostos terapeuticamente ativos e sua utilização | |
CY1114133T1 (el) | ΥΠΟΚΑΤΕΣΤΗΜΕΝΕΣ γ-ΦΑΙΝΥΛ-Δ-ΛΑΚΤΑΜΕΣ ΚΑΙ ΧΡΗΣΕΙΣ ΠΟΥ ΣΧΕΤΙΖΟΝΤΑΙ ΠΡΟΣ ΑΥΤΕΣ | |
ATE364595T1 (de) | Pyridoxin- und pyridoxalanaloga als cardiovasculäre therapeutika | |
DE60144514D1 (de) | Verwendung von il-18 inhibitoren | |
NO20054668L (no) | Aplidin for multippelt myelom-behandling | |
DE60142913D1 (de) | Arzneilösungen enthaltend modafinilverbindungen | |
PT932613E (pt) | Expressao de bloqueio de factoes de virulencia em s. aureus | |
DK0946157T3 (da) | Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte | |
DK1294379T3 (da) | En hidtil ukendt anvendelse af deferipron | |
RS49599B (sr) | Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija | |
ATE405294T1 (de) | Gezielt eingesetzte agenzien zur nervenregeneration | |
DE60229867D1 (de) | Zielgerichtete ligande gegen peyer's flecke- und/oder m-zellen | |
YU39598A (sh) | Upotreba duloksetina i njegova farmaceutska smeša | |
DK1596879T3 (da) | Anvendelse af kahalalidforbindelser til fremstilling af et medikament til behandling af psoriasis | |
DE60236927D1 (de) | Suchtpraevention in der schmerzbehandlung mit gamma vinyl gaba | |
DK1052991T3 (da) | Topisk anvendelse af loperamid til behandling af mikrobielle infektioner | |
SE0203817D0 (sv) | New composition |